BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharma Journalist - ECPv6.16.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.pharmajournalist.com
X-WR-CALDESC:Events for Pharma Journalist
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Asia/Kolkata
BEGIN:STANDARD
TZOFFSETFROM:+0530
TZOFFSETTO:+0530
TZNAME:IST
DTSTART:20190101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20201019
DTEND;VALUE=DATE:20201022
DTSTAMP:20260515T122953
CREATED:20200803T090036Z
LAST-MODIFIED:20200813T133334Z
UID:26605-1603065600-1603324799@www.pharmajournalist.com
SUMMARY:5th Microbiome Movement – Drug Development Summit
DESCRIPTION:The 5th Microbiome Movement – Drug Development Summit (October 19-21\, Digital Event – EDT) continues to be the industry-leading forum to help forward thinking researchers from the pharmaceutical\, biotech and academic community pursue the causal role of the human microbiome in disease\, to create a new generation of targeted treatments that demonstrate consistent clinical outcomes and predictable MoAs. \n \nWith over 60 speakers taking part\, the four focus areas for 2020 include: \n\nPre-Clinical Development & Mechanisms of Microbiome-based Therapeutics\nLearn how industry and academic pioneers are developing novel microbiome platforms to identify new targets and therapeutics across a range of microbiome-targeting modalities and disease phenotypes\nClinical Development\, Manufacturing & Commercialization of Live Biotherapeutics\nAs the industry prepares for pivotal clinical readouts this summer\, this year’s discussion will give you the knowledge and insight required to navigate through the specific translational\, clinical and manufacturing challenges for live biotherapeutics\nMicrobiome-based Biomarkers\, Diagnostics & Patient Stratification\nMine the human microbiome to discover new biomarkers of disease and help predict response\, understand drug metabolism and develop non-invasive diagnostic tools\nApplications in Oncology\nGain a comprehensive insight into the most exciting disease target in microbiome research today with case-studies and discussion from leading cancer researchers\, oncology-specific clinicians and the pharmaceutical industry\n\nIf you are\, or would like to be\, a player in the microbiome arena\, this is the conference you should attend to not only hear the latest pre-clinical and clinical development from organizations developing microbiome-based therapeutics\, biomarkers and diagnostics\, but also to make long-lasting connections that will accelerate your microbiome developments forward\, and help translate this promising science into a reality for patients.
URL:https://www.pharmajournalist.com/event/5th-microbiome-movement-drug-development-summit/
LOCATION:Digital Event – EDT
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20201020
DTEND;VALUE=DATE:20201022
DTSTAMP:20260515T122953
CREATED:20200910T130153Z
LAST-MODIFIED:20200917T151939Z
UID:26975-1603152000-1603324799@www.pharmajournalist.com
SUMMARY:Outsourcing in Clinical Trials Nordics 2020
DESCRIPTION:After the challenges of 2020 with the Covid-19 pandemic\, this is the unmissable event that the pharmaceutical\,\nbiotechnology\, and medical device communities need to come together and discuss strategies for operational success in clinical trials. With all the latest content\, and a big focus on the latest regulations and technology\, the conference will offer an unparalleled opportunity to hear in-depth talks from the likes of the Danish Medicines Agency\, LEO Pharma\, and TÜV SÜD\, as well as C-level and senior experts from the Nordic region. \n\nTo know more about Outsourcing in Clinical Trials Nordics 2020 please click here.
URL:https://www.pharmajournalist.com/event/outsourcing-in-clinical-trials-nordics-2020/
LOCATION:Virtual Event
ORGANIZER;CN="Arena International Events Group":MAILTO:alex.fearn@arena-international.com
END:VEVENT
END:VCALENDAR